Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?

Authors: Daisy Bhatia, Riccardo Dolcetti, Roberta Mazzieri

Published: 2025-03-15

DOI: 10.1186/s13046-025-03359-x

Source: Full article

Abstract

Abstract